Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the preliminary efficacy of nilotinib in pretreated patients
(Imatinib, Sunitinib) with unresectable or metastatic gastrointestinal stromal tumors.